News
BioTechniques - Causing Cancer at (a Chromosome's) Arm's Length
“The question is, could this actually have some significance when it comes to treatment?” said Ayman El-Guindi, a molecular virologist at Yale University familiar with West and her research.
He is certain that it does. El-Guindi pointed out that EZH2, an enzyme overexpressed in cancer cells, is a regulator of BIM. “If you can develop an inhibitor of EZH2 , then you have the opportunity of activating the expression of this gene,” said El-Guindi. In the case of EBV-related carcinogenesis, the reactivated BIM can resume its function to safeguard against cellular immortality and malignancy.
Source: BioTechniques - Causing Cancer at (a Chromosome's) Arm's Length